Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
出版年份 2018 全文链接
标题
Temozolomide and Pituitary Tumors: Current Understanding, Unresolved Issues, and Future Directions
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2018-06-15
DOI
10.3389/fendo.2018.00318
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- 65 YEARS OF THE DOUBLE HELIX: Treatment of pituitary tumors with temozolomide: an update
- (2018) Luis V Syro et al. ENDOCRINE-RELATED CANCER
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
- (2017) S L Asa et al. ENDOCRINE-RELATED CANCER
- Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas
- (2017) Hélène Lasolle et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review
- (2017) Hormones-International Journal of Endocrinology and Metabolism
- Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort
- (2017) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Successful treatment of pituitary carcinoma with concurrent radiation, temozolomide, and bevacizumab after resection
- (2017) Waseem Touma et al. JOURNAL OF CLINICAL NEUROSCIENCE
- MGMT and MSH6 immunoexpression for functioning pituitary macroadenomas
- (2017) Alexander S. G. Micko et al. Pituitary
- APNG as a prognostic marker in patients with glioblastoma
- (2017) Sigurd Fosmark et al. PLoS One
- Temozolomide analogs with improved brain/plasma ratios – Exploring the possibility of enhancing the therapeutic index of temozolomide
- (2016) Roopa Rai et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The conserved molecular machinery in DNA mismatch repair enzyme structures
- (2016) Flora S. Groothuizen et al. DNA REPAIR
- A history of the DNA repair and mutagenesis field
- (2016) Errol C. Friedberg DNA REPAIR
- DNA Replication—A Matter of Fidelity
- (2016) Rais A. Ganai et al. MOLECULAR CELL
- Is there a role for early chemotherapy in the management of pituitary adenomas?
- (2016) Andrew L. Lin et al. NEURO-ONCOLOGY
- How effective is temozolomide for treating pituitary tumours and when should it be used?
- (2016) Carmel Halevy et al. Pituitary
- Bifunctional alkylating agent-mediated MGMT-DNA cross-linking and its proteolytic cleavage in 16HBE cells
- (2016) Jin Cheng et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks
- (2016) Angelo Fortunato et al. Cold Spring Harbor Perspectives in Medicine
- Distinctive adaptive response to repeated exposure to hydrogen peroxide associated with upregulation of DNA repair genes and cell cycle arrest
- (2016) Gloria A. Santa-Gonzalez et al. Redox Biology
- Eukaryotic Mismatch Repair in Relation to DNA Replication
- (2015) Thomas A. Kunkel et al. Annual Review of Genetics
- Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells
- (2015) Jessian L. Munoz et al. CANCER LETTERS
- Invasive, Atypical and Aggressive Pituitary Adenomas and Carcinomas
- (2015) Aydin Sav et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Deficient mismatch repair: Read all about it (Review)
- (2015) SUSAN RICHMAN INTERNATIONAL JOURNAL OF ONCOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center
- (2015) Filippo Ceccato et al. JOURNAL OF NEURO-ONCOLOGY
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- In vitro human cell line models to predict clinical response to anticancer drugs
- (2015) Nifang Niu et al. PHARMACOGENOMICS
- Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications
- (2015) Christian P. Miermeister et al. Acta Neuropathologica Communications
- Aggressive pituitary adenomas—diagnosis and emerging treatments
- (2014) Antonio Di Ieva et al. Nature Reviews Endocrinology
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- From old alkylating agents to new minor groove binders
- (2013) Stéphane Puyo et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- The Role of Temozolomide in the Treatment of a Patient with a Pure Silent Pituitary Somatotroph Carcinoma
- (2013) Leonardo Neto et al. Endocrine Practice
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Molecular status of pituitary carcinoma and atypical adenoma that contributes the effectiveness of temozolomide
- (2013) Akira Matsuno et al. Medical Molecular Morphology
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas
- (2013) C-H Fan et al. Cell Death & Disease
- Aberrant Expression of N-Methylpurine-DNA Glycosylase Influences Patient Survival in Malignant Gliomas
- (2012) Ce Liu et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
- (2012) Tor-Christian Aase Johannessen et al. NEURO-ONCOLOGY
- Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
- (2012) Koji Yoshimoto et al. Frontiers in Oncology
- O6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistry
- (2011) Markus Christmann et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
- (2011) E. M. Goellner et al. CANCER RESEARCH
- DNA glycosylases: in DNA repair and beyond
- (2011) Angelika L. Jacobs et al. CHROMOSOMA
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pituitary Carcinoma: Difficult Diagnosis and Treatment
- (2011) Anthony P. Heaney JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Alkylpurine–DNA–N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients
- (2011) Sameer Agnihotri et al. JOURNAL OF CLINICAL INVESTIGATION
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- Certain Imidazotetrazines Escape O6-Methylguanine-DNA Methyltransferase and Mismatch Repair
- (2011) Jihong Zhang et al. ONCOLOGY
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Treatment of pituitary neoplasms with temozolomide
- (2010) Luis V. Syro et al. CANCER
- SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
- (2010) H. Bode et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- DNA Damage Response
- (2010) G. Giglia-Mari et al. Cold Spring Harbor Perspectives in Biology
- Chemical biology of mutagenesis and DNA repair: cellular responses to DNA alkylation
- (2009) N. Shrivastav et al. CARCINOGENESIS
- An Overview of Chemical Processes That Damage Cellular DNA: Spontaneous Hydrolysis, Alkylation, and Reactions with Radicals
- (2009) Kent S. Gates CHEMICAL RESEARCH IN TOXICOLOGY
- Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
- (2008) Lucio Tentori et al. CURRENT MEDICINAL CHEMISTRY
- New (alternative) temozolomide regimens for the treatment of glioma
- (2008) Wolfgang Wick et al. NEURO-ONCOLOGY
- Management of aggressive pituitary adenomas: current treatment strategies
- (2008) Michael Buchfelder Pituitary
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now